Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on May 22, 2024 6:31pm
92 Views
Post# 36052962

RE:RE:RE:Investor attitude toward management

RE:RE:RE:Investor attitude toward management
alleyesonme wrote: It's on the investors deck MD&A and was mentioned on the last CC.  Do I believe what they say...yes I do...clearly they can't discuss more otherwise they would..this is a fact I posted the sedan links and pages last week, why do you continue to deny this fact...MPL has a client/partner who've submitted and NDA..ANDA is another completely different venture..so is the 505b2..three drug approvals pending.  


The investor deck says a good many things, including having forward looking cautionary notes among other statements that can be used to explain that not all statements made are as you clearly take them.

As explained earlier, if you choose to believe that the investor deck which states that the business has partners in 'all phases', which includes NDA, ANDA etc, then very good, believe that, I do as well.

However what they actually mean by those statements leaves much to intepretation and this is where our opinions clearly diverge.  You obviously believe that their 'partner' has submitted or will imminently submit a NDA say, while I believe that the statements they made certainly indicate that they are working with a partner that has every intention of submitting a NDA but has not and will not in the near term.  Why do I believe that, because the business has not stated anything material about that effort apart from what the deck shows, which is to say they are working with partners in 'all phases'.  They have spoken about the ANDA certainly, and we all know, given the slip up from Keith on a recent call, that it is indeed Epidiolex.  But the company has said absolutely nothing about the NDA.

Remember our lesson about fact vs. truth?  I deal in facts.
<< Previous
Bullboard Posts
Next >>